Oral vaccination with attenuated Salmonella enterica strains encoding T-cell epitopes from tumor antigen NY-ESO-1 induces specific cytotoxic T-lymphocyte responses

Clinical and Vaccine Immunology

Volumn 17, Issue 6, 2010, Pages 889-894

  Meng, Jia Zi ^a   Dong, Yu Jun ^b   Huang, He ^c   Li, Shuang ^a   Zhong, Yi ^b   Liu, Shu Lin ^d,e   Wang, Yue Dan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGFA PROTEIN; ALANINE; BACTERIAL DNA; CANCER VACCINE; CONGO RED; EPITOPE; FIMBRIA PROTEIN; HLA A ANTIGEN; NY ESO 1 ANTIGEN; PEPTIDE VACCINE; PROTEIN ANTIBODY; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BINDING ASSAY; CANCER IMMUNIZATION; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FIMBRIA; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SEROTYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; EPITOPES, T-LYMPHOCYTE; FIMBRIAE PROTEINS; HLA-A ANTIGENS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, ATTENUATED;

EID: 77953172060     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00044-10     Document Type: Article

References (40)

1. Ayyoub, M., A. Zippelius, M. J. Pittet, D. Rimoldi, D. Valmori, J. C. Cerottini, P. Romero, F. Lejeune, D. Lienard, and D. E. Speiser. 2003. Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1. Clin. Cancer Res. 9:669-677.
2. Benitez, A. J., N. McNair, and J. R. Mead. 2009. Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice. Clin. Vaccine Immunol. 16:1272-1278.
3. Bernhard, E. J., A. X. Le, J. A. Barbosa, E. Lacy, and V. H. Engelhard. 1988. Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells. J. Exp. Med. 168:1157-1162.
4. Choi, E. M., J. L. Chen, L. Wooldridge, M. Salio, A. Lissina, N. Lissin, I. F. Hermans, J. D. Silk, F. Mirza, M. J. Palmowski, P. R. Dunbar, B. K. Jakobsen, A. K. Sewell, and V. Cerundolo. 2003. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J. Immunol. 171:5116-5123.
5. Collinson, S. K., L. Emody, K. H. Muller, T. J. Trust, and W. W. Kay. 1991. Purification and characterization of thin, aggregative fimbriae from Salmonella enteritidis. J. Bacteriol. 173:4773-4781.
6. Doran, J. L., S. K. Collinson, J. Burian, G. Sarlos, E. C. Todd, C. K. Munro, C. M. Kay, P. A. Banser, P. I. Peterkin, and W. W. Kay. 1993. DNA-based diagnostic tests for Salmonella species targeting agfA, the structural gene for thin, aggregative fimbriae. J. Clin. Microbiol. 31:2263-2273.
7. Ebert, L. M., Y. C. Liu, C. S. Clements, N. C. Robson, H. M. Jackson, J. L. Markby, N. Dimopoulos, B. S. Tan, I. F. Luescher, I. D. Davis, J. Rossjohn, J. Cebon, A. W. Purcell, and W. Chen. 2009. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res. 69:1046-1054.
8. Echchannaoui, H., M. Bianchi, D. Baud, M. Bobst, J. C. Stehle, and D. Nardelli-Haefliger. 2008. Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer. Infect. Immun. 76:1940-1951.
9. Garcia Casado, J., J. Janda, J. Wei, L. Chapatte, S. Colombetti, P. Alves, G. Ritter, M. Ayyoub, D. Valmori, W. Chen, and F. Levy. 2008. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo. Eur. J. Immunol. 38:1867-1876.
10. Garmory, H. S., R. W. Titball, K. A. Brown, and A. M. Bennett. 2003. Construction and evaluation of a eukaryotic expression plasmid for stable delivery using attenuated Salmonella. Microb. Pathog. 34:115-119.
11. Gnjatic, S., D. Atanackovic, E. Jager, M. Matsuo, A. Selvakumar, N. K. Altorki, R. G. Maki, B. Dupont, G. Ritter, Y. T. Chen, A. Knuth, and L. J. Old. 2003. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proc. Natl. Acad. Sci. U. S. A. 100:8862-8867.
12. Gnjatic, S., E. Jager, W. Chen, N. K. Altorki, M. Matsuo, S. Y. Lee, Q. Chen, Y. Nagata, D. Atanackovic, Y. T. Chen, G. Ritter, J. Cebon, A. Knuth, and L. J. Old. 2002. CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. Proc. Natl. Acad. Sci. U. S. A. 99:11813-11818.
13. Gnjatic, S., H. Nishikawa, A. A. Jungbluth, A. O. Gure, G. Ritter, E. Jager, A. Knuth, Y. T. Chen, and L. J. Old. 2006. NY-ESO-1: review of an immunogenic tumor antigen. Adv. Cancer Res. 95:1-30.
14. Haga, T., S. Kumabe, A. Ikejiri, Y. Shimizu, H. Li, Y. Goto, H. Matsui, H. Miyata, and T. Miura. 2006. In vitro and in vivo stability of plasmids in attenuated Salmonella enterica serovar Typhimurium used as a carrier of DNA vaccine is associated with its replication origin. Exp. Anim. 55:405-409.
15. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
16. Huang, H., Y. J. Wang, A. P. White, J. Z. Meng, G. R. Liu, S. L. Liu, and Y. D. Wang. 2009. Salmonella expressing a T-cell epitope from Sendai virus are able to induce anti-infection immunity. J. Med. Microbiol. 58:1236-1242.
17. Isoda, R., S. P. Simanski, L. Pathangey, A. E. Stone, and T. A. Brown. 2007. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector. Vaccine 25:117-126.
18. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
19. Jager, E., Y. Nagata, S. Gnjatic, H. Wada, E. Stockert, J. Karbach, P. R. Dunbar, S. Y. Lee, A. Jungbluth, D. Jager, M. Arand, G. Ritter, V. Cerundolo, B. Dupont, Y. T. Chen, L. J. Old, and A. Knuth. 2000. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. U. S. A. 97:4760-4765.
20. Karbach, J., S. Gnjatic, C. Pauligk, A. Bender, M. Maeurer, J. L. Schultze, K. Nadler, C. Wahle, A. Knuth, L. J. Old, and E. Jager. 2007. Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination. Int. J. Cancer 121:2042-2048.
21. Kulkarni, R. R., V. R. Parreira, S. Sharif, and J. F. Prescott. 2008. Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens. Vaccine 26:4194-4203.
22. Le, A. X., E. J. Bernhard, M. J. Holterman, S. Strub, P. Parham, E. Lacy, and V. H. Engelhard. 1989. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142:1366-1371.
23. Lopes, L., M. Dewannieux, U. Gileadi, R. Bailey, Y. Ikeda, C. Whittaker, M. P. Collin, V. Cerundolo, M. Tomihari, K. Ariizumi, and M. K. Collins. 2008. Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses. J. Virol. 82:86-95.
24. Massis, L. M., C. J. Braga, M. E. Sbrogio-Almeida, C. Lauand, S. M. Newton, P. E. Klebba, and L. C. Ferreira. 2008. Anti-flagellin antibody responses elicited in mice orally immunized with attenuated Salmonella enterica serovar Typhimurium vaccine strains. Mem. Inst. Oswaldo Cruz 103:606-610.
25. Nishikawa, H., E. Sato, G. Briones, L. M. Chen, M. Matsuo, Y. Nagata, G. Ritter, E. Jager, H. Nomura, S. Kondo, I. Tawara, T. Kato, H. Shiku, L. J. Old, J. E. Galan, and S. Gnjatic. 2006. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J. Clin. Invest. 116:1946-1954.
26. Palmowski, M. J., E. M. Choi, I. F. Hermans, S. C. Gilbert, J. L. Chen, U. Gileadi, M. Salio, A. Van Pel, S. Man, E. Bonin, P. Liljestrom, P. R. Dunbar, and V. Cerundolo. 2002. Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. J. Immunol. 168:4391-4398.
27. Palmowski, M. J., L. Lopes, Y. Ikeda, M. Salio, V. Cerundolo, and M. K. Collins. 2004. Intravenous injection of a lentiviral vector encoding NYESO-1 induces an effective CTL response. J. Immunol. 172:1582-1587.
28. Pasare, C., and R. Medzhitov. 2004. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21:733-741.
29. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036.
30. Peng, G., Z. Guo, Y. Kiniwa, K. S. Voo, W. Peng, T. Fu, D. Y. Wang, Y. Li, H. Y. Wang, and R. F. Wang. 2005. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309:1380-1384.
31. Peterson, A. C., H. Harlin, and T. F. Gajewski. 2003. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J. Clin. Oncol. 21:2342-2348.
32. Qu, D., S. Wang, W. Cai, and A. Du. 2008. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine 26:4541-4548.
33. Römling, U., Z. Bian, M. Hammar, W. D. Sierralta, and S. Normark. 1998. Curli fibers are highly conserved between Salmonella typhimurium and Escherichia coli with respect to operon structure and regulation. J. Bacteriol. 180:722-731.
34. Spreng, S., G. Dietrich, and G. Weidinger. 2006. Rational design of Salmonella-based vaccination strategies. Methods 38:133-143.
35. Wang, Y. J., Y. Hou, H. Huang, G. R. Liu, A. P. White, and S. L. Liu. 2008. Two oral HBx vaccines delivered by live attenuated Salmonella: both eliciting effective anti-tumor immunity. Cancer Lett. 263:67-76.
36. White, A. P., E. Allen-Vercoe, B. W. Jones, R. DeVinney, W. W. Kay, and M. G. Surette. 2007. An efficient system for markerless gene replacement applicable in a wide variety of enterobacterial species. Can. J. Microbiol. 53:56-62.
37. White, A. P., S. K. Collinson, P. A. Banser, D. J. Dolhaine, and W. W. Kay. 2000. Salmonella enteritidis fimbriae displaying a heterologous epitope reveal a uniquely flexible structure and assembly mechanism. J. Mol. Biol. 296:361-372.
38. White, A. P., S. K. Collinson, J. Burian, S. C. Clouthier, P. A. Banser, and W. W. Kay. 1999. High efficiency gene replacement in Salmonella enteritidis: chimeric fimbrins containing a T-cell epitope from Leishmania major. Vaccine 17:2150-2161.
39. Xu, C., Z. S. Li, Y. Q. Du, Y. F. Gong, H. Yang, B. Sun, and J. Jin. 2007. Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H. pylori ureB and IL-2. World J. Gastroenterol. 13:939-944.
40. Yang, Y., C. T. Huang, X. Huang, and D. M. Pardoll. 2004. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 5:508-515.